Impact of Induction Treatment on Stem Cell Collection: A COVID Related Study

Introduction: Standard induction therapy for multiple myeloma consists of 3-6 cycles of bortezomib, lenalidomide, and dexamethasone (VRd) or carfilzomib, lenalidomide and dexamethasone (KRd). Receiving greater than 6 cycles of a lenalidomide containing regimen is thought to negatively impact the abi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rybinski, Brad, Badros, Ashraf Z., Rapoport, Aaron P., Kocoglu, Mehmet Hakan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
711.Cell Collection and Processing
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701605/
http://dx.doi.org/10.1182/blood-2021-149812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701605/
http://dx.doi.org/10.1182/blood-2021-149812

Ejemplares similares